Rare lephants
Screener

Protalix BioTherapeutics, Inc.

PLX ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
CT ORDER Dec 4, 2018
10-Q Nov 7, 2018 FORM 10-Q
8-K Nov 7, 2018 FORM 8-K
DEF 14A Oct 17, 2018 DEFINITIVE PROXY STATEMENT
PRE 14A Oct 5, 2018 PRELIMINARY PROXY STATEMENT
8-K Oct 5, 2018 FORM 8-K
8-K Sep 21, 2018 FORM 8-K
4 Sep 14, 2018 OWNERSHIP DOCUMENT
4 Sep 14, 2018 OWNERSHIP DOCUMENT
4 Sep 14, 2018 OWNERSHIP DOCUMENT
4 Sep 14, 2018 OWNERSHIP DOCUMENT
4 Sep 14, 2018 OWNERSHIP DOCUMENT
3 Aug 13, 2018 FORM 3
8-K Aug 13, 2018 FORM 8-K
10-Q Aug 9, 2018 FORM 10-Q
8-K Aug 9, 2018 FORM 8-K
8-K Jul 24, 2018 8-K
3 Jun 8, 2018 OWNERSHIP DOCUMENT
S-8 Jun 8, 2018 FORM S-8
8-K May 31, 2018 FORM 8-K
8-K May 24, 2018 FORM 8-K
8-K May 14, 2018 FORM 8-K
10-Q May 9, 2018 FORM 10-Q
8-K May 9, 2018 FORM 8-K
DEFA14A Apr 18, 2018 DEFA14A
← Newer Page 14 of 38 · 935 filings Older →